These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29759422)

  • 21. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
    Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Antonio Iribarren J; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P;
    Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):396-412. PubMed ID: 11153204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002].
    Rubio R; Berenguer J; Miró JM; Antela A; Iribarren JA; González J; Guerra L; Moreno S; Arrizabalaga J; Clotet B; Gatell JM; Laguna F; Martínez E; Parras F; Santamaría JM; Tuset M; Viciana P
    Enferm Infecc Microbiol Clin; 2002; 20(6):244-303. PubMed ID: 12084354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with lopinavir/ritonavir plus lamivudine for initial ART in HIV infected adults.
    Gatell Artigas JM; Arribas López JR; Lázaro Y de Mercado P; Blasco Bravo AJ
    Enferm Infecc Microbiol Clin; 2016; 34(7):427-30. PubMed ID: 25749416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
    Blasco AJ; Llibre JM; Berenguer J; González-García J; Knobel H; Lozano F; Podzamczer D; Pulido F; Rivero A; Tuset M; Lázaro P; Gatell JM;
    Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):156-65. PubMed ID: 25175171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Executive summary of the GeSIDA consensus document on control and monitoring of HIV-infected patients.
    AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology
    Enferm Infecc Microbiol Clin (Engl Ed); 2019; 37(7):467-475. PubMed ID: 29793873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
    Ambrosioni J; Levi L; Alagaratnam J; Van Bremen K; Mastrangelo A; Waalewijn H; Molina JM; Guaraldi G; Winston A; Boesecke C; Cinque P; Bamford A; Calmy A; Marzolini C; Martínez E; Oprea C; Welch S; Koval A; Mendao L; Rockstroh JK;
    HIV Med; 2023 Nov; 24(11):1126-1136. PubMed ID: 37849432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
    Rivero A; Pérez-Molina JA; Blasco AJ; Arribas JR; Asensi V; Crespo M; Domingo P; Iribarren JA; Lázaro P; López-Aldeguer J; Lozano F; Martínez E; Moreno S; Palacios R; Pineda JA; Pulido F; Rubio R; Santos J; de la Torre J; Tuset M; Gatell JM
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 May; 36(5):268-276. PubMed ID: 28532596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Consensus statement on assistance to women with human immunodeficiency virus infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA)].
    ;
    Enferm Infecc Microbiol Clin; 2014 Feb; 32(2):99.e1-99.e14. PubMed ID: 23896395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comedication prescription patterns and potential for drug-drug interactions with antiretroviral therapy in people living with human immunodeficiency virus type 1 infection in Germany.
    Lopes S; O'Day K; Meyer K; Van Stiphout J; Punekar Y; Radford M; Haas JS
    Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):270-278. PubMed ID: 31950545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Executive summary of the consensus statement on assistance to women with HIV infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA).
    ;
    Enferm Infecc Microbiol Clin; 2014 Feb; 32(2):100-5. PubMed ID: 23931832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort.
    Ma J; Nance RM; Delaney JAC; Whitney BM; Bamford L; Gravett RM; Moore RD; Napravnik S; Mayer KH; Jacobson JM; Christopoulos K; Burkholder GA; Keruly J; Eron JJ; Martin J; Cachay ER; Saag MS; Crane HM; Kitahata MM
    Clin Infect Dis; 2022 Sep; 75(4):715-718. PubMed ID: 35134850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [2008 prevention of opportunistic infections in HIV-infected adolescents and adults guidelines. Recommendations of GESIDA/National AIDS Plan AIDS Study Group (GESIDA) and National AIDS Plan].
    ;
    Enferm Infecc Microbiol Clin; 2008; 26(7):437-64. PubMed ID: 18842240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
    Ryom L; De Miguel R; Cotter AG; Podlekareva D; Beguelin C; Waalewijn H; Arribas JR; Mallon PWG; Marzolini C; Kirk O; Bamford A; Rauch A; Molina JM; Kowalska JD; Guaraldi G; Winston A; Boesecke C; Cinque P; Welch S; Collins S; Behrens GMN;
    HIV Med; 2022 Sep; 23(8):849-858. PubMed ID: 35338549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
    Cahn P; Madero JS; Arribas JR; Antinori A; Ortiz R; Clarke AE; Hung CC; Rockstroh JK; Girard PM; Sievers J; Man C; Currie A; Underwood M; Tenorio AR; Pappa K; Wynne B; Fettiplace A; Gartland M; Aboud M; Smith K;
    Lancet; 2019 Jan; 393(10167):143-155. PubMed ID: 30420123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
    Rivero A; Pérez-Molina JA; Blasco AJ; Arribas JR; Crespo M; Domingo P; Estrada V; Iribarren JA; Knobel H; Lázaro P; López-Aldeguer J; Lozano F; Moreno S; Palacios R; Pineda JA; Pulido F; Rubio R; de la Torre J; Tuset M; Gatell JM
    Enferm Infecc Microbiol Clin; 2017 Feb; 35(2):88-99. PubMed ID: 27459919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Executive summary. Consensus statement of the National AIDS Plan Secretariat, Spanish Society of Emergency Medicine and AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology on Emergency and HIV Infection.
    Expert Panel of the National AIDS Plan Secretariat, Spanish Society of Emergency Medicine and AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology
    Enferm Infecc Microbiol Clin; 2013; 31(7):457-60. PubMed ID: 23601917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
    Hammer SM; Eron JJ; Reiss P; Schooley RT; Thompson MA; Walmsley S; Cahn P; Fischl MA; Gatell JM; Hirsch MS; Jacobsen DM; Montaner JS; Richman DD; Yeni PG; Volberding PA;
    JAMA; 2008 Aug; 300(5):555-70. PubMed ID: 18677028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial.
    Winston A; Post FA; DeJesus E; Podzamczer D; Di Perri G; Estrada V; Raffi F; Ruane P; Peyrani P; Crofoot G; Mallon PWG; Castelli F; Yan M; Cox S; Das M; Cheng A; Rhee MS
    Lancet HIV; 2018 Apr; 5(4):e162-e171. PubMed ID: 29475804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Consensus statement on the clinical management of non-AIDS defining malignancies. GeSIDA expert panel].
    Santos J; Valencia E;
    Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):515-22. PubMed ID: 24953385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.